⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMEA News
Biomea Fusion, Inc. Common Stock
Form 8-K
sec.gov
BMEA
Biomea Fusion to Participate at Upcoming Investor Conferences
globenewswire.com
BMEA
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
globenewswire.com
BMEA
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
BMEA
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
globenewswire.com
BMEA
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
globenewswire.com
BMEA
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
globenewswire.com
BMEA
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BMEA
Biomea Fusion to Participate at Upcoming Investor Conferences
globenewswire.com
BMEA
Biomea Fusion to Participate at Jefferies London Healthcare Conference
globenewswire.com
BMEA